Burden of upper gastrointestinal symptoms in patients prescribed dabigatran for stroke prevention

BACKGROUND: Dabigatran, a non-vitamin K antagonist oral anticoagulant, has been shown to prevent stroke in patients with non-valvular atrial fibrillation. Nonetheless, studies show that 10%–30% of those prescribed dabigatran experience dyspepsia that may eventually lead to discontinuation of therapy...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:SAGE Open Med
Asıl Yazarlar: Chan, Pak-Hei, Hai, Jo-Jo, Huang, Duo, Ho, Mei-Han, Chan, Esther W, Cheung, Bernard Man-Yung, Chan, Annie On-On, Wong, Ian Chi-Kei, Tse, Hung-Fat, Hung, Ivan Fan-Ngai, Siu, Chung-Wah
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2016
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4976790/
https://ncbi.nlm.nih.gov/pubmed/27551422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050312116662414
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller